⚠️ This website is for educational and informational purposes only! Ibogaine is a controlled substance in many countries. Nothing here constitutes medical advice. Always consult a qualified physician.

Healing Trauma, Restoring Hope

Championing ibogaine-assisted therapy as a breakthrough treatment for PTSD, traumatic brain injury, and addiction — when Israel needs it most.

85,000+

Israelis currently receiving treatment for war-related psychological trauma

88% Reduction in PTSD symptoms after ibogaine treatment (Stanford, 2024)
85,000+ IDF soldiers treated for PTSD since Oct. 7, 2023
4 Founders dedicated to change
35+ Years of ibogaine advocacy in Israel

Aerial view of Jerusalem
Support group circle discussion

Brain research visualization

Project Iron Mind - IDF veterans support

The Ibogaine Registry - research data

Survivor Outreach - community support

Patient Subsidy Fund - financial assistance

1

2

3

Israelis for Ibogaine  ·  עמותת איבוגאין ישראל

Two women embracing in hope

IDF soldier with neural network overlay

Articles & Insights

Brain research
Research January 2024

Stanford's Landmark Study: Ibogaine Reduces PTSD by 88% in Veterans

A peer-reviewed study published in Nature Medicine confirms ibogaine's extraordinary efficacy for traumatic brain injury and PTSD. Here's what it means for Israel.

Read More →
Community support circle
History March 2024

From Gabon to the Clinic: The Remarkable History of Ibogaine

The iboga plant has been sacred to Bwiti communities for centuries. We trace the journey from Central African rainforests to modern psychiatric clinics.

Read More →
Embracing hope
Israel October 2024

October 7 and After: Israel's Mental Health Crisis Demands Bold Solutions

With 85,000 soldiers receiving psychological treatment and therapist shortages reaching crisis levels, conventional approaches are falling short.

Read More →
Veteran therapy session
Parkinson's June 2024

Can Ibogaine Help Parkinson's Patients? Early Evidence Is Promising

Ibogaine's ability to stimulate GDNF — a key neurotrophic factor for dopamine neurons — is opening new possibilities for neurodegenerative disease treatment.

Read More →
The Knesset
Advocacy December 2024

Israel Needs Ibogaine: The Case for Fast-Tracking Regulatory Approval

As Texas allocates $50 million for ibogaine clinical trials, Israel must move swiftly to ensure its trauma survivors have access to the world's most promising new therapy.

Read More →
Support group
Recovery February 2025

Howard Lotsof's Gift: The Discovery That Changed Everything

In 1962, a 19-year-old heroin addict named Howard Lotsof took ibogaine and woke up free. His life's work created the global ibogaine treatment movement.

Read More →

Ibogaine in the Media

Dr. Raquel Gardner — Ibogaine for Traumatic Brain Injury & PTSD

Dr. Raquel Gardner is a U.S. board-certified behavioral neurologist, Associate Professor at Tel Aviv University School of Medicine, and Director of Clinical Research at the Joseph Sagol Neuroscience Center, Sheba Medical Center. Her NIH- and DoD-funded research focuses on traumatic brain injury, aging, and neurodegenerative disease — and since October 7, war-related TBI across the full spectrum of severity. GardnerLab · Sheba Medical Center

How Ibogaine Therapy is Changing Lives for Veterans

In Search of Hope: Veterans Turn to Psychedelic Treatment

Ibogaine: Rite of Passage — Full Documentary

Contact the Foundation

Whether you are a patient seeking information, a researcher interested in collaboration, a journalist, or someone who simply wants to get involved — we want to hear from you.

✉️
info@ibogainefoundation.org.il
📍
Tel Aviv, Israel
✓ Thank you! We will be in touch soon.